Wenhao Yu
Research Interests
Wenhao Yu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Bingyu Ren
1 shared publication- Boyuan Gu
Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
1 shared publication Cheng Liu
1 shared publicationJiatong Chen
1 shared publication- Junjie Bai
Department of General Surgery (Hepatopancreatobiliary Surgery, Biliary-Pancreatic Center), The Affiliated Hospital, Southwest Medical University, Luzhou, China
1 shared publication Lei Sun
1 shared publication
Latest Publications
- Open Access
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
SERPING1, a biomarker associated with colorectal liver metastasis, promotes colorectal cancer cell proliferation, migration, and invasion
BackgroundColorectal liver metastasis (CRLM) is a major cause of mortality in patients with colorectal cancer (CRC). However, the underlying molecular mechanisms remain unclear. Therefore, identifying the key genes associated with CRLM and elucidating their functional roles are of critical importance.MethodsWeighted gene co-expression network analysis (WGCNA), differential expression analysis, and Kaplan–Meier survival analysis were performed to identify the CRLM-associated hub genes. SERPING1 expression was validated in human tissue samples. In vitro assays were performed to assess the effects of SERPING1 on CRC cell proliferation, migration, and invasion. Epithelial–mesenchymal transition (EMT)-related pathways were also analyzed. Single-cell RNA sequencing data were used to explore the involvement of SERPING1 in the tumor microenvironment.ResultsSERPING1 was identified as a hub gene associated with CRLM, and was significantly upregulated in CRLM tissues. Functional assays demonstrated that SERPING1 promotes CRC cell proliferation, migration, and invasion and is associated with the activation of EMT-related pathways. Single-cell RNA sequencing analysis revealed that SERPING1 was predominantly enriched in cancer-associated fibroblasts (CAFs) and was correlated with immune infiltration patterns related to CAFs.ConclusionsThese findings suggest that SERPING1 may play a pro-metastatic role in CRLM and represents a promising biomarker and potential therapeutic target for colorectal liver metastasis.
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSERPING1, a biomarker associated with colorectal liver metastasis, promotes colorectal cancer cell proliferation, migration, and invasion
BackgroundColorectal liver metastasis (CRLM) is a major cause of mortality in patients with colorectal cancer (CRC). However, the underlying molecular mechanisms remain unclear. Therefore, identifying the key genes associated with CRLM and elucidating their functional roles are of critical importance.MethodsWeighted gene co-expression network analysis (WGCNA), differential expression analysis, and Kaplan–Meier survival analysis were performed to identify the CRLM-associated hub genes. SERPING1 expression was validated in human tissue samples. In vitro assays were performed to assess the effects of SERPING1 on CRC cell proliferation, migration, and invasion. Epithelial–mesenchymal transition (EMT)-related pathways were also analyzed. Single-cell RNA sequencing data were used to explore the involvement of SERPING1 in the tumor microenvironment.ResultsSERPING1 was identified as a hub gene associated with CRLM, and was significantly upregulated in CRLM tissues. Functional assays demonstrated that SERPING1 promotes CRC cell proliferation, migration, and invasion and is associated with the activation of EMT-related pathways. Single-cell RNA sequencing analysis revealed that SERPING1 was predominantly enriched in cancer-associated fibroblasts (CAFs) and was correlated with immune infiltration patterns related to CAFs.ConclusionsThese findings suggest that SERPING1 may play a pro-metastatic role in CRLM and represents a promising biomarker and potential therapeutic target for colorectal liver metastasis.